New hope for kidney patients: drug may slow damage without standard meds

NCT ID NCT07181135

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 29 times

Summary

This study tests if the drug finerenone can reduce protein leakage in urine (a sign of kidney damage) better than a placebo. It involves 180 adults with chronic kidney disease who are not taking certain common blood pressure medicines. The goal is to see if finerenone can help control the disease and prevent further kidney decline.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clínica Universidad de Navarra

    Madrid, Spain

  • Clínica Universidad de Navarra

    Pamplona, Spain

  • Hospital Clinico Universitario de Valencia

    Valencia, Spain

  • Hospital Universitari Germans Trias i Pujol

    Barcelona, Spain

  • Hospital Universitario Dr Peset

    Valencia, Spain

  • Hospital Universitario Puerta de Hierro

    Madrid, Spain

  • Hospital Universitario de La Princesa

    Madrid, Spain

  • Vall d'Hebron University Hospital

    Barcelona, Spain

Conditions

Explore the condition pages connected to this study.